These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 16285963)
1. Short hairpin RNA modulates transforming growth factor beta signaling in life-threatening liver failure in mice. Mizuguchi Y; Yokomuro S; Mishima T; Arima Y; Shimizu T; Kawahigashi Y; Kanda T; Yoshida H; Takizawa T; Tajiri T Gastroenterology; 2005 Nov; 129(5):1654-62. PubMed ID: 16285963 [TBL] [Abstract][Full Text] [Related]
2. [Inhibiting scar formation in rat cutaneous wounds by blocking TGF-beta signaling]. Liu W; Chua CH; Wu XL; Wang DR; Yin DM; Cui L; Cao YL; Longaker MT Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):31-6. PubMed ID: 12757642 [TBL] [Abstract][Full Text] [Related]
3. TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Flentjar N; Chu PY; Ng AY; Johnstone CN; Heath JK; Ernst M; Hertzog PJ; Pritchard MA Gastroenterology; 2007 Apr; 132(4):1410-9. PubMed ID: 17408644 [TBL] [Abstract][Full Text] [Related]
4. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491 [TBL] [Abstract][Full Text] [Related]
5. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Go C; Li P; Wang XJ Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147 [TBL] [Abstract][Full Text] [Related]
6. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Oe S; Lemmer ER; Conner EA; Factor VM; Levéen P; Larsson J; Karlsson S; Thorgeirsson SS Hepatology; 2004 Nov; 40(5):1098-105. PubMed ID: 15389868 [TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Yata Y; Gotwals P; Koteliansky V; Rockey DC Hepatology; 2002 May; 35(5):1022-30. PubMed ID: 11981752 [TBL] [Abstract][Full Text] [Related]
8. Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo. Ikeda Y; Imai Y; Kumagai H; Nosaka T; Morikawa Y; Hisaoka T; Manabe I; Maemura K; Nakaoka T; Imamura T; Miyazono K; Komuro I; Nagai R; Kitamura T Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10732-7. PubMed ID: 15247411 [TBL] [Abstract][Full Text] [Related]
9. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073 [TBL] [Abstract][Full Text] [Related]
10. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation. Fukuda M; Kurosaki H; Sairenji T J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876 [TBL] [Abstract][Full Text] [Related]
11. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells. Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646 [TBL] [Abstract][Full Text] [Related]
12. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue. Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833 [TBL] [Abstract][Full Text] [Related]
14. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells. Ishikawa F; Nose K; Shibanuma M Exp Cell Res; 2008 Jun; 314(10):2131-40. PubMed ID: 18433744 [TBL] [Abstract][Full Text] [Related]
16. Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes. Meyer C; Godoy P; Bachmann A; Liu Y; Barzan D; Ilkavets I; Maier P; Herskind C; Hengstler JG; Dooley S J Hepatol; 2011 Aug; 55(2):369-78. PubMed ID: 21184784 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor cell growth in the liver by RNA interference-mediated suppression of HIF-1alpha expression in tumor cells and hepatocytes. Takahashi Y; Nishikawa M; Takakura Y Gene Ther; 2008 Apr; 15(8):572-82. PubMed ID: 18273056 [TBL] [Abstract][Full Text] [Related]
19. Combination gene therapy of HGF and truncated type II TGF-beta receptor for rat liver cirrhosis after partial hepatectomy. Ozawa S; Uchiyama K; Nakamori M; Ueda K; Iwahashi M; Ueno H; Muragaki Y; Ooshima A; Yamaue H Surgery; 2006 Apr; 139(4):563-73. PubMed ID: 16627068 [TBL] [Abstract][Full Text] [Related]
20. Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene. Haiping Z; Takayama K; Uchino J; Harada A; Adachi Y; Kura S; Caicun Z; Tsuzuki T; Nakanishi Y Cancer Gene Ther; 2006 Sep; 13(9):864-72. PubMed ID: 16710346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]